Trial Profile
An observational study of IKT-001Pro in patients who contracted Progressive Multifocal Leukoencephalopathy
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs IKT 001PRO (Primary)
- Indications Progressive multifocal leukoencephalopathy
- Focus Therapeutic Use
- 20 Aug 2015 New trial record